Decapentaplegic (Dpp) signaling determines the number of cells that migrate dorsally to form the dorsal primary branch during tracheal development. We report that Dpp signaling is also required for the differentiation of one of three different cell types in the dorsal branches, the fusion cell. In Mad mutant embryos or in embryos expressing dominant negative constructs of the two type I Dpp receptors in the trachea the number of cells expressing fusion cell-speci®c marker genes is reduced and fusion of the dorsal branches is defective. Ectopic expression of Dpp or the activated form of the Dpp receptor Tkv in all tracheal cells induces ectopic fusions of the tracheal lumen and ectopic expression of fusion gene markers in all tracheal branches. Among the fusion marker genes that are activated in the trachea in response to ectopic Dpp signaling is Delta. In conditional Notch loss of function mutants additional tracheal cells adopt the fusion cell fate and ectopic expression of an activated form of the Notch receptor in fusion cells results in suppression of fusion cell markers and disruption of the branch fusion. The number of cells that express the fusion cell markers in response to ectopic Dpp signaling is increased in Notch ts1 mutants, suggesting that the two signaling pathways have opposing effects in the selection of the fusion cells in the dorsal branches. q
Introduction
During organogenesis complex signaling mechanisms determine the gradual differentiation of an increasing number of different groups of cells within the organ primordium. These different cell populations subsequently undergo the coordinated execution of distinct morphogenetic programs that give rise to the three-dimensional structure of the organ. The cellular processes underlying the development of Drosophila tracheal system include the outgrowth of primary tubes, sprouting of new unicellular branches, and branch fusion to interconnect independent tubes into a network (Manning and Krasnow, 1993) . Each of these steps is controlled by regulatory signaling events that ensure the formation of a stereotypically patterned organ.
The Drosophila trachea network is formed from twenty independent metameric units each composed of t 80 invaginating epidermal cells. Unlike branching in the lung and the vertebrate circulatory system, tracheal branching does not involve cell division or cell death (Samakovlis et al., 1996a) . During primary branching tracheal cells form six buds that grow on stereotyped tracts. Mutants in genes of the Spitz and Decapentaplegic (Dpp) pathways encoding homologs of the mammalian EGF and TGFb growth factors are severely impaired in primary branching (Vincent et al., 1997; Wappner et al., 1997) . Mutants of the Spitz group primarily affect anterior-posterior migration whereas mutations in the genes of the Dpp pathway selectively affect dorsal and ventral migrations of the tracheal cells. The two signaling pathways appear to antagonize each other, just before or during the invagination of the tracheal cells from the epidermis, to de®ne the number of cells that will migrate along the anterior-posterior or the dorso-ventral axis (Wappner et al., 1997) . The stereotyped cell migrations during primary branching are guided by the localized expression of branchless (bnl), a homolog of vertebrate FGF. Bnl activates the tyrosine kinase receptor Breathless (Btl) and its downstream components (Michelson et al., 1998; Vincent et al., 1998; Imam et al., 1999) in the migrating tracheal cells and attracts them towards its sites of expression (Lee et al., 1996; Sutherland et al., 1996) .
Btl activation also results in the expression of a set of genes in the leading cells of the migrating primary branches, www.elsevier.com/locate/modo the pantip genes. A subset of the cells expressing the pantip markers then become selected to express either of two groups of marker genes and undergo two distinct programs of secondary branching, terminal branching or branch fusion. Terminal marker genes are also activated in response to Bnl signaling and the cells expressing them extend unicellular sprouts towards extra tracheal target tissues, where they later ramify to generate a large number of tracheoles. The ®ve fusion cells in each metamere also extend unicellular sprouts, but these contact the corresponding cells of neighboring metameres to mediate the 50 branch fusion events that interconnect the 20 independent branching units (Fig. 1A and Samakovlis et al., 1996b) . Dorsal trunk and lateral trunk fusion events connect adjacent tracheal metameres on each side of the embryo during stage 13 and stage 15 of embryonic development, while the fusion of the dorsal, cephalic and ventral anastomoses connect the contra-lateral sides of the tracheal network later at stage 16. Fusion of capillaries in amphibians and mammals is also carried out by single cell sprouts (Clark and Clark, 1939; Wolff and Ba Èr, 1972 ) and tubule fusion is also a prerequisite in the formation of a functional kidney, but despite its importance in tubular organ development, very little is known about the molecules that induce and control branch fusion. In Drosophila, the dorsal branch of a typical tracheal abdominal metamere is only composed of 5 cells. One of these will undergo terminal branching and one will form a fusion sprout whereas the remaining three cells will form the stalk of the branch surrounding its lumen ( Fig. 1B ; Samakovlis et al., 1996a) . The limited number of cells and their characteristic positions at the end of embryogenesis make the dorsal branch an amenable model to study the mechanisms of differentiation of the fusion cell. So far, six marker genes have been identi®ed to be selectively expressed in the fusion cells during tracheal development. Among these, escargot (esg) encoding a zink-®nger transcription factor, is required for the activation of three of the fusion marker genes and the repression of terminal marker genes in the fusion cells (Samakovlis et al., 1996b) . Thus esg is a key regulator of branch fusion. The tracheal phenotypes of mutants in headcase (hdc) one of the esg targets, indicate that hdc participates in a signaling event deriving from the fusion cells to inhibit the remaining cells of the branch to acquire the terminal cell fate (Steneberg et al., 1998) . esg is also required for the up-regulation of DEcadherin in the fusion cells .
In this study we address the signaling events that specify the fusion cell fate at the tip of the dorsal branch. We ®nd that activation of the Dpp pathway induces the expression of fusion cell marker genes, including esg and hdc. The selection of single cells among the Dpp responsive cells is accomplished by the up-regulation of the Delta ligand in the presumptive fusion cell and the activation of the Notch receptor in the cells that remain at the stalk of the branch. These results provide a link between the signaling mechanisms involved in fusion cell differentiation and downstream genes necessary for the morphogenetic events of branch fusion.
Results

Inactivation of genes in the Dpp signaling pathway selectively affects dorsal branch fusion
During primary branching (stage 11±12) the 5±6 cells that form the dorsal bud all express the same set of pantracheal and regionally restricted tracheal marker genes. The ®rst difference in gene expression among them becomes apparent during stages 12 and 13 when a group of marker genes is expressed in 3 to 4 cells at the leading end of the branch. The expression of these markers is dynamic, as it gradually becomes restricted to two cells at stage 14 and ®nally becomes stronger in the terminal cell at stage 15 ( Fig. 1B ; Samakovlis et al., 1996a) . In addition, at stage 13 the term- . (E and F) Stage 16 embryos that carry both a UAS-bnl and a hs-Gal4 transgene. Ubiquitous Bnl expression was induced by heatshock at stage 11. In these embryos several extra terminal branches sprout off each DB (E; embryo stained as in C), which express the terminal marker, DSRF (F; embryo stained as in D), but still only one cell per DB expresses Hdc (arrow in E and F). Scale bars are 5 mm.
inal and fusion cell markers initiate their expression in two distinct cells within the group expressing the pantip markers. These gradual changes in marker gene expression suggest that a group of cells ®rst becomes induced to express the pantip genes and a subset of these is then selected to express either the terminal or fusion genes. A powerful inducer of pantip and terminal gene expression is Bnl (Sutherland et al., 1996) . Ectopic expression of Bnl under control of the heat shock promoter (hsp70) leads to an increased number of cells expressing pantip and terminal markers in all tracheal branches ( Fig. 1F ; Sutherland et al., 1996) . We tested whether Bnl can also activate the expression of fusion markers in more than one cell in the dorsal branch by ectopically expressing Bnl in wild type embryos under the hsp70 promoter and staining with antibodies against the fusion marker gene hdc. Bnl overexpression did not affect the expression of hdc; like in wild-type embryos, hdc was expressed in a single cell at the tip of the dorsal branch in embryos expressing high levels of Bnl (Fig. 1C,E ). The same treatment was able to induce the ectopic expression of the terminal marker, Drosophila serum response factor (DSRF), (Guillemin et al., 1996) , in up to 4 additional cells in the dorsal branch (Fig. 1F) . Thus, Bnl can induce the activation of pantip and terminal markers in almost all cells of the dorsal branch, but it is not suf®cient to ectopically activate fusion markers.
An alternative inductive signal for the expression of fusion cell markers may be provided by Dpp. Dpp is expressed in dorsolateral epidermal clusters located near the tips of the outgrowing dorsal branches (Vincent et al., 1997) and the Dpp receptor, Thick vein (Tkv) is expressed in all tracheal cells during embryogenesis and is required for in dorsal branch outgrowth (Llimargas and Casanova, 1997; Vincent et al., 1997) . In tkv 7 homozygous embryos many of the dorsal branches are severely reduced or absent and in the cases where dorsal branches are formed, they never fuse and neither do they express Hdc fusion marker (data not shown). To further characterize the effect of Dpp signaling in the trachea we analyzed the phenotypes of mutants lacking the zygotic function of Mothers against dpp (Mad). Mad is a key effector of Dpp signaling in the developing eye (Wiersdorff et al., 1996) but the embryonic tracheal phenotype in zygotic Mad mutants is not as severe as in tkv mutants, presumably due to the longer lasting maternally contributed product. In mutant embryos of two different alleles of Mad (Mad 12 and Mad
B1
) 20% (n 106) of the dorsal branch fusion events are disrupted. In several of these branches the fusion cells extend a sprout but do not contact their appropriate fusion partners. In addition Hdc is absent in 6.5% of the dorsal branches (n 168) in Mad 12 mutants (Fig. 2C ,D and data not shown). In order to selectively reduce Dpp signaling in the trachea we used two dominant negative constructs of the type I receptors, UAS-tkv1D GSK and UAS-saxD I (Haerry et al., 1998) , and expressed these under the control of the fusion cell speci®c driver p127-Gal4. Expression of the two dominant negative constructs in the fusion cells disrupts fusion in 19% of the dorsal branches with UAS-tkv1D GSK (n 80) and with UASsaxD I (n 90). Disruption of fusion is accompanied by the suppression of hdc expression in 42% of the dorsal branches for UAS-tkv1D GSK (n 30) and in 59% of the branches for UAS-saxDI (n 34), suggesting a failure in fusion cell differentiation ( Fig. 2B and data not shown). The expression of terminal markers in these embryos was activated in an additional cell in t 5% of the branches, perhaps as a result of the suppression of hdc in the fusion cell ( Fig.  2H and data not shown). In the same experiment, using the btl-Gal4 driver which is expressed in all tracheal cells, we also observed defects in dorsal branch fusion and suppression of hdc and esg-lacZ markers, although at a lower frequency (Fig. 2F) . Thus, interference with the function of the Dpp receptors in the fusion cells results in defects in branch fusion, suppression of fusion cell markers and the weak ectopic activation of terminal markers in additional cells of the dorsal branches.
Ectopic activation of Dpp signaling induces the expression of fusion cell markers in additional cells
To further investigate whether the Dpp pathway is involved in the induction of fusion cell fate, we ectopically expressed the Dpp ligand and asked whether we can detect ectopic activation of fusion markers in cells of the dorsal branch. We selectively expressed UAS-dpp (Ruberte et al., 1995) in tracheal cells under the control of the btl-GAL4 driver strain and assayed for the expression of esg-lacZ and hdc. In these embryos, the esg-lacZ reporter was expressed in one additional cell in 28% (n 160) of the branches and hdc could also be detected in an extra cell in 13% of the branches (n 114) (Fig. 3C ,J). To test whether this response is due to the activation of the Dpp pathway in the trachea, we expressed a constitutively active form of the Dpp receptor, tkv Q253D (Nellen et al., 1996) , under the control of the same Gal4 driver. UAS-tkv Q253D is also capable of inducing the fusion cell fate in the dorsal branches as it induces ectopic expression of the same fusion markers (Fig. 3E, 
L). With UAS-tkv
Q253D the increase of esglacZ positive cells was detected in 18% (n 160) of the dorsal branches and an extra hdc expressing cell was found in and 11% (n 140) of the branches. In parallel experiments, where we assayed for the expression of terminal cell markers after ectopic activation of Dpp in the trachea, we observed both an increase and a decrease in the number of cells expressing DSRF in different dorsal branches. These changes however, did not correlate with an increase or decrease in numbers of cells expressing the fusion cell markers. In 5.2% (n 240) of the dorsal branches of btlGal4;UAS-tkv Q253D embryos DSRF was expressed in two cells whereas in 10.4% of the branches of the same embryos DSRF was not expressed at all. Thus, ectopic expression of Dpp can ectopically activate fusion cell markers, and it also has a variable effect on the expression of terminal cell markers.
The effects of Dpp in marker gene expression may be indirect since ectopic activation of the pathway in the trachea also drastically increases the number of cells that migrate dorsally to form the dorsal branches at the expense of the number of cells forming the dorsal trunk (Vincent et al., 1997) . In this scenario, the increased number of cells expressing the fusion markers would be due to the increased number of cells migrating dorsally and thus being exposed to an as yet unidenti®ed signal inducing fusion marker expression. We therefore examined the effect of ectopic activation of Dpp in the expression of fusion markers in the dorsal trunk, where the number of cells migrating along the anterior-posterior axis becomes severely reduced upon pantracheal expression of Dpp or Tkv Q253D . esg-lacZ which is normally expressed in the two dorsal trunk fusion cells of each metamere (Fig. 3I) , becomes ectopically expressed in more than two cells upon ectopic activation of the Dpp pathway (Fig. 3K,M) . Furthermore, hdc which is never expressed in the dorsal trunk in wild-type embryos becomes activated in two cells at the dorsal trunk fusion junction of the same embryos (Fig. 3B,D) . Taken together these results suggest that Dpp signaling in the trachea can selectively induce fusion cell fate.
Delta is expressed in the fusion cell and becomes ectopically activated in response to Dpp
Ectopic activation of Dpp signaling in all tracheal cells leads to ectopic activation of fusion cell markers in a single additional cell at the tip of the branch. This localized ability to respond may argue for the presence of inhibitory mechanisms determining the selection of fusion cell fates. In a In wild-type embryos, each of the two DBs contains one fusion cell, which expresses Hdc (A; asterisks). The fusion process is disrupted in embryos that express the dominant negative construct tkv1D GSK under the control of the fusion cell speci®c driver p127-Gal4 (B) and in embryos of two different mutant alleles of Mad (C and D). Expression of Hdc is also suppressed in these embryos (arrows in B, C and D), but some branches still express Hdc (asterisk in B and C). (E,F) Embryos heterozygous for the esg-lacZ marker and stained for b-galactosidase and tracheal lumen, both in brown. In wild type embryos, the fusion cells express the esg-lacZ marker (E; asterisks). In embryos that ectopically express saxDI in all tracheal cells, controlled by the btl-Gal4 driver, branch fusion is disrupted and esg-lacZ expression is suppressed (F; arrow). (G,H) Embryos stained for DSRF and tracheal lumen, both in brown. In wild type embryos (G) DSRF is expressed in the terminal cell of each DB. In embryos that ectopically express saxDI in the fusion cells, using the P127-Gal4 driver, DSRF is occasionally activated in one additional cell (H; arrowhead). Dashed lines in (H) represent DB and DT that are out of focus. Scale bar is 5 mm.
screen for enhancer trap strains that are selectively expressed in the fusion cells during tracheal development we have recently isolated several alleles of Delta, a ligand for the Notch receptor that plays a pivotal role in the differentiation of many cell types during development (Zeng et al., 1998) . The P-element insertion in the strain l(s)14231 was mapped at position 92A on the polytene chromosomes and did not complement the lethality of the Delta alleles, Dl RF , Dl 6B and P1651. We found that the lacZ marker in the l(s)14231 and P1651 strains is generally expressed at low levels in all tracheal cells during primary branching, but it becomes strongly expressed in the fusion cells of all branches at embryonic stage 13 (Fig. 4A,B and data not shown). This up-regulation of Delta-lacZ in the fusion cells is coincident with the activation of the earliest fusion markers esg-lacZ and Fusion-2 (Samakovlis et al., 1996a) . Given the effect of Dpp signaling on the expression of the fusion markers, we examined whether Delta-lacZ expression may also be induced by Dpp signaling. In btl-Gal4/ UAS-dpp embryos Delta-lacZ was expressed in one to two additional cells of the dorsal branch and dorsal trunk (Fig. 4C,D) . This ectopic activation of the marker was also detected in embryos expressing the activated form of the Dpp receptor, Tkv Q253D , in all tracheal cells (Fig. 4E,F) , suggesting that Notch signaling may function in the selection of the fusion cell during tracheal development.
In Notch ts1 mutants more cells adopt fusion cell fate
Notch signaling is an evolutionary conserved mechanism that controls cell fate through local cell interactions (Artavanis-Tsakonas et al., 1999) . Notch has been shown to play a key role in the development of a number of embryonic tissues, including the trachea (Hartenstein et al., 1992) but because of the large number of processes that require Notch during embryogenesis its function in the trachea remains unclear. To address the function of Notch in branch fusion we analyzed embryos deriving from the Notch ts1 mutant strain, a temperature sensitive allele of the Notch receptor that is thought to re¯ect the complete loss of function condition of the Notch gene at the restrictive temperature (Baker and Yu, 1997) . Notch ts1 embryos were subjected to the restrictive temperature for 1 h at stage 11±12 and allowed to develop to stage 16 before ®xation and analysis for expression of tracheal marker genes. The expression domain of all of the four fusion markers tested was expanded to an additional cell in several of the dorsal branches of Notch ts1 embryos (Fig. 5B,D and data not shown). The esg-lacZ marker was expressed in an extra cell in 18% (n 256) of the branches, the Fusion-2 marker in 11% (n 140) of the branches and Hdc was expressed in an additional cell in 13% (n 160) of the dorsal branches. Among the fusion markers whose expression was up-regulated in Notch ts1 embryos was also the Delta-lacZ marker. Labeling of the tracheal lumen, the Hdc protein and the Delta-lacZ marker in Notch ts1 embryos revealed that the additional cells expressing Hdc also express elevated levels of Delta-lacZ (Fig. 5F ). To identify the origin of the additional cells expressing fusion markers in Notch mutants, we ®rst stained Notch ts1 embryos for Hdc and a pantracheal marker to facilitate counting of the number of cells in the affected branches. This experiment revealed that the increase in cells expressing the fusion markers was not due to a general increase in the number of cells of the dorsal branch, since the total number of cells (5.5 cells; n 15) in the affected dorsal branches was very similar to the number of cells in wild type embryos (5.4 cells; n 119). We then stained Notch ts1 embryos with antibodies against the tracheal lumen and the terminal cell marker DSRF. The number of cells expressing the terminal marker is not reduced in the mutant, instead we ®nd a weak increase (3.5%, n 192) in the number of branches containing two DSRF expressing cells. Thus, the expression of fusion markers in an additional cell in the Notch ts1 embryos is not due to the transformation of a terminal cell into a fusion cell. Since the total number of cells in the dorsal branches also remains the same in the mutants, we conclude that the extra fusion cell derives from the group of cells that normally remain at the stalk of the dorsal branch.
Ectopic activation of Notch signaling in fusion cells abolish fusion cell fate
The increased number of cells adopting the fusion cell fate in the dorsal branches and the up-regulation of DeltalacZ in the fusion cells during tracheal development indicate that the fusion cell signals to the following cells in the stalk preventing them from expressing fusion markers. We examined the effect of ectopic activation of the Notch receptor by expressing a UAS-Notch intra construct (Go et al., 1998) in all tracheal cells using the btl-Gal4 driver strain. This truncated form of the Notch receptor has been shown to mimic the effect of Notch activation upon ligand binding in several of the developmental decisions involving Notch signaling (Celis and Bray, 1997) . Notch intra expression in the tracheal cells results in a dramatic phenotype. The branching pattern of 20 tracheal metameric units appears normal, but the metameres remain unconnected at the end of embryogenesis (Fig. 6I,J) . The expression of esg-lacZ and hdc fusion markers is also severely affected since , 90% of the dorsal branches fail to express these markers, suggesting a defect in fusion cell differentiation (Fig. 6D,E) . The expression of the terminal cell marker DSRF was not drastically changed in these embryos. In 5% of the dorsal branches we could detect one additional cell at the tip of the dorsal branches expressing the DSRF marker (data not shown). This phenotype resembles the loss of function phenotype of hdc, and since Hdc is absent from the fusion cells of these embryos, it is likely that ectopic expression of DSRF is due to the , is ectopically expressed using the btl-Gal4 driver (arrows in C±F). Scale bar is 5 mm.
defects in fusion gene expression. The tracheal phenotypes of Notch ts1 mutants and the fusion cell-speci®c defects in embryos expressing Notch intra in all tracheal cells suggest that the Notch pathway is activated in the stalk cells of the tracheal branches by Delta, to inhibit them from acquiring the fusion cell fate. To further test this hypothesis we expressed the UAS-Notch intra construct selectively in the fusion cells under the control of the p127-Gal4 driver. In this strain Gal4 is expressed in several tissues during embryogenesis but within the trachea it is exclusively expressed in the fusion cells at stage 13. In embryos expressing UASNotch intra under the control of the p127-Gal4 driver 63% (n 140) of the dorsal branches do not fuse and 48% (n 140) of the branches do not express the fusion cell marker Hdc (Fig. 6G) . The lower frequency of the phenotypes compared to the phenotypes observed with btl-Gal4 driver may be due to earlier expression of btl-Gal4 in the trachea at stage 11. These results argue that activation of Notch can inhibit fusion cell differentiation.
Notch signaling restricts the response to Dpp to a single cell of the dorsal branch
In the dorsal branches Dpp signaling is necessary for the expression of fusion cell markers and the formation of the dorsal anastomosis. Furthermore, ectopic activation of the Dpp pathway can induce the expression of the fusion marker genes, including a Delta-lacZ marker, in an additional cell in the stalk of the branch. In loss of function Notch mutants additional cells express the fusion cell markers, including Delta-lacZ, and ectopic activation of the Notch signaling pathway in the fusion cells leads to branch fusion defects in all tracheal branches and inhibition of fusion marker gene expression. Thus, Dpp is an inductive signal for the fusion cell fate and Delta an inhibitory one. To further examine the relationship between the two signaling pathways in the selection of the fusion cells of the dorsal branches we ectopically activated the Dpp signaling in Notch ts1 mutant embryos. In embryos with an intact Notch function ectopic expression of Dpp or an activated form of its receptor results in the expression of fusion markers in an additional cell per branch (Fig. 7A,B) . Conversely, inactivation of Notch function in the Notch ts1 mutants also leads to expression of the fusion markers in one additional cell. However, upon expression of UAS-dpp or UAS-tkv Q253D in Notch ts1 mutant embryos can often induce three extra cells expressing hdc fusion marker at the tip of the dorsal branch (Fig. 7B,C) . These results suggest that Notch signaling in the trachea restricts the number of cells that acquire the fusion cell fate in response to the inductive Dpp signal.
Discussion
Dpp signaling induces the fusion cell fate in the dorsal branches
Dpp expression in dorsal epidermal cells adjacent to the growing dorsal branches is required for branch outgrowth and for the transcriptional activation of genes like knirps and knirps related in the migrating cells of the dorsal branch (Llimargas and Casanova, 1997; Vincent et al., 1997; Chen et al., 1998) . These genes function early in tracheal development and determine the number of cells that migrate dorsally towards the attractant signal derived from the cells expressing bnl (Sutherland et al., 1996) . Our results uncover an additional function of Dpp in the trachea. It is necessary for the differentiation of one of the three different cell types of the dorsal branch, the fusion cell. Ectopic activation of Dpp signaling leads to the expression of fusion marker genes in more than one cell in the dorsal branch, and these cells become competent to undergo ectopic fusion events. In addition, partial inactivation of Dpp signaling, either by removing the zygotic function of the downstream mediator Mad or by expression of dominant negative forms of its receptors in the fusion cells, results in dorsal branch fusion defects. Accordingly, the fusion cell marker genes are not expressed in the affected branches. However, these effects of Dpp signaling on fusion marker gene expression in the dorsal branch could be indirect since Dpp also determines the number of cells that will migrate dorsally during primary branching (Vincent et al., 1997) . Evidence for a direct effect of Dpp on fusion fate induction comes from the ectopic expression of fusion markers in the dorsal trunk upon ectopic activation of the Dpp pathway. In spite of the severe reduction in the number of cells migrating along the anterior-posterior axis to form the dorsal trunk branches, esg-lacZ and hdc become ectopically expressed in the dorsal trunk, arguing for a direct role of Dpp in the induction of fusion cell fate. One fusion cell in each DB expresses Hdc in wild type embryos (A; asterisks), however, upon induced expression of Notch intra , DB fusion is disrupted and Hdc expression is suppressed with both the btl-Gal4 (D; arrows) and p127-Gal4 fusion cell speci®c driver (G; arrows). (B, E) Embryos are heterozygous for the esg-lacZ marker and were stained for b-galactosidase and lumen both in brown. Expression of esg-lacZ in the DB fusion cells in wild type embryos (B; asterisks) is suppressed in the disrupted DBs when Notch intra is expressed with btl-Gal4 driver (E; arrows). (C, F and H) Embryos are stained for DSRF and tracheal lumen both in brown. Expression pattern of DSRF is still retained in a single cell in each DB in embryos carrying UAS-Notch intra under the control of btl-Gal4 (F; arrowheads) or p127-Gal4 (H; arrowheads) driver. Scale bar is 5 mm.
Notch signaling is required for fusion cell speci®cation
In an enhancer trap screen for genes that are selectively expressed in the tracheal fusion cells we have identi®ed several alleles of Delta. In these strains the Delta-lacZ marker is initially expressed homogeneously in all tracheal cells, but becomes up-regulated in the fusion cell from embryonic stage 13, approximately at the same time that the ®rst fusion marker genes initiate their expression in the fusion cell. Inactivation of Notch signaling by a conditional allele of the receptor results in more cells acquiring the fusion cell fate. Delta-lacZ is also up-regulated in the extra fusion cells indicating that Notch signaling in the trachea also regulates the expression of the Delta ligand, as has been suggested for other Notch signaling events. In Notch ts1 mutants the total number of cells in the dorsal branch remains the same and the number of cells expressing the terminal cell marker is not decreased. Thus, Notch is required for the suppression of the fusion cell program in the three cells that will remain in the stalk of the branch. Accordingly, expression of an activated form of Notch in all tracheal cells, or in the fusion cells only, inhibits branch fusion and suppresses the expression of fusion marker genes. Cell counts in these affected dorsal branches show that the number of cells is unchanged suggesting that the presumptive fusion cell does not undergo apoptosis but instead remains in the stalk of the branch. However, in embryos expressing the activated form of Notch in all trachea, a few additional cells express the terminal marker genes and sprout off the dorsal branches, but this is likely due to the inability of the presumptive fusion cell to produce the Hdc inhibitor.
Notch selects single cells of the dorsal branches that undergo branch fusion in response to Dpp
We have shown here, that the localized expression of Dpp in the dorsal epidermis is required for the induction of the fusion cell fate, whereas Notch signaling has the opposite effect in the expression of fusion marker genes. Since the number of cells that acquire the fusion cell fate in response to Dpp becomes higher when the amount of functional Notch is reduced, we propose that Notch signaling in the trachea is required for the selection of a single fusion cell among the group of cells that receive the Dpp signal at the tip of the dorsal branch. Furthermore, Dpp signaling can activate expression of Delta suggesting that Delta expression in the fusion cell may be directly activated by downstream effectors of Dpp signaling. Such transcription factors include Mad, Knirps and Knirps-like which recently have been shown to act downstream of Dpp signaling during primary branching (Chen et al., 1998) . Alternatively the activation of Delta in the cells in the stalk of the branch may be suppressed by negative regulators of Dpp signaling like Daughters against Dpp (Dad) or Brinker, both of which are regulated by Dpp signaling (Campbell and Tomlinson, 1999; Tsuneizumi et al., 1997) .
The requirement for Dpp signaling in branch fusion does not seem to be a general theme for all tracheal branches. Dpp is not expressed in the proximity of the dorsal trunk fusion cells and dorsal trunk fusion is not affected in embryos mutant for Mad, tkv or expressing the dominant negative forms of the receptors in all tracheal cells. These results argue that the induction of fusion cell fate in different branches employs different signaling mechanisms. Such a signaling event that may be responsible for the activation of fusion genes in the dorsal trunk may be provided by the Spi/ EGFR pathway (Wappner et al., 1997) . Mutations in members of this pathway are defective in dorsal trunk formation, and in the developing Drosophila wing, rhomboid, a component of EGF signaling has been shown to regulate the expression of Delta (Sturtevant et al., 1993) . In contrast to the local requirement of Dpp in the dorsal branch, Notch signaling is a prerequisite for the selection of the fusion cell in all primary branches that will extend a fusion sprout. Thus, even though the inductive signals required for the expression of the fusion cell-speci®c marker genes may be different they all appear to result in the upregulation of Delta and signaling through Notch to select a single cell at tip of the branch that will execute the complex cellular dynamics of branch fusion.
Experimental procedures
Drosophila strains
The Dl-lacZ enhancer trap strains, l(3)S142311 and l(3)S049520, were isolated in a screen for tracheal branch fusion genes, using the 3rd chromosome enhancer trap collection obtained from J. Szidonya (Deak et al., 1997) . Other enhancer traps used are l(2)07082 (esg-lacZ) and l(2)07769 (Fusion-2) (Samakovlis et al., 1996a) , P1651 (Dl-lacZ; Bloomington Stock Center). The pantracheal lacZ marker was (1-eve-1) (Perrimon et al., 1991) , and was used for tracheal cell counts.
The following esg, N, Dl, tkv and Mad alleles were used: N ts1 ,Dl RF and Dl 6B (Baker and Zitron, 1995) , tkv 7 (Umea Ê Stock Center), Mad 12 and Mad B1 (Wiersdorff et al., 1996) . N ts1¯i es were kept at 188C unless otherwise indicated. To inactivate N, eggs were collected for 8 h at 188C or 4 h at room temperature, incubated until embryonic stage 12 (16 h at 188C or 11.5 h at room temperature after egg laying) followed by 1 h heat treatment at 31.58C. Embryos were then incubated at room temperature until stage 16 before ®xation.
UAS/Gal4 strains
For ectopic expression of different genes the UAS/Gal4 system was used (Brand and Perrimon, 1993) . The following strains were used: UAS-dpp (on second chromosome; Ruberte et al., 1995) , UAS-tkv Q253D (on third chromosome; Nellen et al., 1996) , UAS-Notch intra (on third chromosome; described as act.N in Go et al., 1998) , UAS-saxD I and UAStkv1D GSK (both constructs on second and third chromosomes; Haerry et al., 1998) , hs-Gal4 and UAS-bnl (Sutherland et al., 1996) .
The btl-Gal4 strains express high levels of Gal4 in the tracheal placode from embryonic stage 11 and onwards (Shiga et al., 1996) and the p127-Gal4 strain expresses Gal4 in tracheal fusion cells from stage 13.
Eggs were collected for 6 h at room temperature, then incubated for 11 h at 298C before ®xation. Eggs from crosses between hs-Gal4 and UAS-bnl¯ies were collected for 6 h at room temperature, and 7 h later, the embryos were heat treated at 378C for 20 min followed by recovery at 188C for 30 min and incubation at room temperature until stage 16.
For ectopic expression of either UAS-dpp or UAS-tkv
Q253D
in N ts1 mutants, embryos from the two following crosses were analyzed: N ts1 /1;UAS-dpp/1 £ N ts1
;btl-Gal4/1 and N ts1 /1; UAS-tkv Q253D /1 £ N ts1
;btl-Gal4/1 (female genotype is ®rst). Embryos were collected for 6 h at 208C and then incubated for 11 h at 298C. Embryos that carry both btl-Gal4 and UASdpp (or UAS-tkv Q253D ) are identi®ed by their strong tracheal phenotype. Of these, 50% are homozygous for N ts1 and these are identi®ed by their marked increase in Hdc expressing cells, when compared to embryos carrying btl-Gal4/UASdpp (or UAS-tkv Q253D ) in Notch1/1 background.
Embryo ®xation and staining
Embryos were ®xed for 20 min and stained as described (Steneberg et al., 1998) unless otherwise indicated. The mouse IgM mAb2A12 was used at 1:3 to visualize tracheal lumen. Rabbit antiserum against b -galactosidase (Cappel) was used at 1:1500. The anti-DSRF monoclonal antibody, mAb2-161 (from Michael Gilman; Adriad Corporation, Boston, MA), was used at 1:1000, and the anti-Hdc monoclonal antibody (Weaver and White, 1995) was used at 1:1. Biotinylated secondary antibodies (Jackson) were used at 1:300 followed by avidin-horseradish peroxidase (HRP) histochemistry. Cy3-(Jackson) and Cy2-(Amersham) conjugated antibodies and strepavidin-Cy2 and -Cy3 (Amersham) were visualized by confocal microscopy.
For staining with the Hdc antibody, embryos were ®xed for 10 min and Hdc primary and secondary antibodies were incubated for only 1 h in PBT (0.3% Triton X-100) at room temperature. For double labeling, embryos were ®rst stained and developed for Hdc, and then stained and developed for mAb2A12, b -galactosidase or DSRF. Embryo staging was according to Campos-Ortega and Hartenstein (1985) . Embryos were mounted in methylsalicylate and analyzed by DIC light microscopy or by confocal microscopy as described (Steneberg et al., 1998) .
Addendum
A manuscript entitled``The Notch pathway helps to pattern the tips of the Drosophila tracheal branches by selecting cell fates'' by M. Llimargas was recently published in Development 126 (1999) 2355±2364. Llimargas reached independently the same conclusion that Notch signaling is necessary to restrict the fusion cell fate to a single cell at the tip of the fusing tracheal branches. The author also suggests in her manuscript that Notch signaling may have an additional function in selecting the terminal cell fate, which is induced by Bnl signaling. Although we have not extensively addressed this putative additional role of Notch and Delta in our work, our results do not support such a conclusion.
